Wednesdays, 1:00–2:00 p.m., BRC 3C211
Drug design for substance use disorders
Amy Newman, Ph.D.
Acting Scientific Director, NIDA IRP
Chief, Molecular Targets & Medications Discovery Branch
Animal models for studying addiction
Charles Bradberry, Ph.D.
Chief, Preclinical Pharmacology Section
Behavioral Neuroscience Branch
Compulsive methamphetamine consumption in the presence of punishment: Epigenetic and transcriptional consequences
Jean Lud Cadet, M.D.
Chief, Molecular Neuropsychiatry Branch
Developing molecular tools: Sometimes your control is the interesting part of the experiment
Brandon Harvey, Ph.D.
Chief, Molecular Mechanisms of Cellular Stress & Inflammation Unit
Integrative Neuroscience Branch
What can MRI tell us about the human brain and drug abuse?
Tom Ross, Ph.D.
Staff Scientist, Cognitive & Affective Neuroscience of Addiction Section
The anatomy of a clinical trial
Kenzie Preston, Ph.D.
Chief, Clinical Pharmacology & Therapeutics Branch